Research shows that GLP-1 medications can help individuals lose up to 15% of their body weight
In summary, GLP-1 drugs like Ozempic exert their therapeutic effects by activating GLP-1 receptors in the gut, leading to a coordinated response aimed at improving glycemic control, impacting appetite and gastric emptying, and preserving pancreatic function
GLP-1s have opened new possibilities in obesity and chronic condition care
Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance
But with this growth has come increased regulatory scrutinyand a few significant legal developments that are now shaping the future of how these medications are accessed
Losing a substantial fraction of it in the process of achieving weight loss is, in metabolic terms, trading one problem for another